Natera, Inc. operates as a diagnostics company. The Company provides preconception and prenatal genetic testing services. Natera also offers pre-implantation genetic diagnosis, aneuploidy screening, translocation, and single gene testing services.

Current Report (Form 8-K | Period ending 2024-11-12)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Natera Inc (NTRA US)

Current Report (Form 8-K | Period ending 2024-11-12)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-08-08)

Current Report (Form 8-K | Period ending 2024-06-12)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)